Caroli's disease (CD) is a rare congenital abnormality characterized by dilatation of intra-hepatic bile ducts, recurrent cholangitis, formation of calculi inside these ducts with normal extra hepatic ducts and higher risk for cholangiocarcinoma. Association of this disease with congenital hepatic fibrosis is named as Caroli's syndrome. We reported 30 years old women with recurrent epigastric pain for 2 years with normal Liver function Test however involving both lobes of liver who developed cholangiocarcinoma approximately 6 months later.
Introduction
Caroli's disease was first described by Caroli as a congenital malformation of intrahepatic bile ducts,characterized by segmental cystic dilatation of the intra hepatic duct;increased incidence of biliarylithiasis; cholangitis, Liver abscess, absence of cirrhosis and portal hypertension; and association with renal tubular ectasia or similar renal cystic disease. 1 Association of this anomaly with congenital hepatic fibrosis and portal hypertension is named as Caroli's syndrome. This disease affects about 1 in 10, 00000 people with more reported cases of Caroli's syndrome than Caroli's disease. Caroli's disease is typically found in Asia and under 22 years of age. The cause of the disease appears to be genetic, while Caroli's disease is an autosomal dominant trait; the complex Caroli's syndrome is an autosomal recessive trait. Caroli's disease is distinct from other diseases that causes ductal dilatation caused by obstruction in that it is not one of the many choledocal cyst derivatives. It is necessary to demonstrate that the Caroli's disease is localized or diffuse from the point of view of treating the disease. Caroli's disease if localized to one lobe, can be treated with lobectomy, not only to get rid of the disease but also to prevent malignant transformation.
Removal of calculi and sphincterotomy may be needed Cholangiocarcinoma which occurs in 7% of cases is a fatal complication. 2 In our case while we did a regular follow up of our patients, we didn't come across any other complications. But after about 6 months when she came for a follow up, she had considerable loss of weight, jaundice, anorexia and distension of abdomen.
We therefore, decided to exclude malignant change and subjected her for another CECT and we found that she already had cholangiocarcinoma. Although the case was still operable we couldn't either treat her in our hospital due to lack up infrastructure facility, nor could we refer her elsewhere as the patient was very poor to afford such a treatment. Cholangiocarcinomatous change should be kept in mine.
Conclusions

